10-Bromo-9-fluoro-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxamide → HCID 71715393, compound

HRID 575218Notes

Reaction equation

HRID 575218 reaction equation
Br[C:2]1[C:3]([F:19])=[CH:4][C:5]2[O:11][CH2:10][CH2:9][N:8]3[CH:12]=[C:13]([C:15]([NH2:17])=[O:16])[N:14]=[C:7]3[C:6]=2[CH:18]=1.[N:20]1[CH:25]=[CH:24][CH:23]=[C:22]([C:26]([OH:30])([C:28]#[CH:29])[CH3:27])[N:21]=1>>[F:19][C:3]1[C:2]([C:29]#[C:28][C:26]([OH:30])([C:22]2[N:21]=[N:20][CH:25]=[CH:24][CH:23]=2)[CH3:27])=[CH:18][C:6]2[C:7]3[N:8]([CH:12]=[C:13]([C:15]([NH2:17])=[O:16])[N:14]=3)[CH2:9][CH2:10][O:11][C:5]=2[CH:4]=1

Participants

3

Procedure

Similar to as described in General Procedure G, 10-bromo-9-fluoro-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxamide was reacted with 2-(pyridazin-3-yl)but-3-yn-2-ol to give the titled compound as a brown solid (26 mg, 9%).

Sources & evidence

ORD record
ord-4ebf355f44774daaa1b1537c2063aad3
Source dataset
uspto-grants-2015_05
Patent number
US09034866B2

Reaction notes

Loading…